DS
HCAT icon

David Shaw’s Health Catalyst HCAT Stock Holding History

David Shaw’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-113,641
Closed -$272K – 4743
2025
Q4 		$272K Buy
113,641
+36,981
+48% +$101K ﹤0.01% 4200
2025
Q3 		$218K Buy
+76,660
New +$262K ﹤0.01% 4244
2025
Q2 		– Sell
-208,651
Closed -$945K – 4483
2025
Q1 		$945K Buy
208,651
+195,686
+1,509% +$1.04M ﹤0.01% 3119
2024
Q4 		$91.7K Sell
12,965
-79,341
-86% -$632K ﹤0.01% 4172
2024
Q3 		$751K Buy
92,306
+49,865
+117% +$360K ﹤0.01% 3468
2024
Q2 		$271K Buy
+42,441
New +$272K ﹤0.01% 3947

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's HCAT Position: Q1 2026 in Review

David Shaw sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 113,641 shares — an estimated $272K sold.

David Shaw first reported a position in HCAT in Q2 2024 and held it in 6 quarters. The position peaked at $945K in Q1 2025. 131 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • David Shaw reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • David Shaw sold 113,641 Health Catalyst shares in Q1 2026, an estimated $272K.
  • David Shaw first reported a position in Health Catalyst in Q2 2024 and held it in 6 quarters.
  • David Shaw's Health Catalyst position peaked at $945K in Q1 2025.
  • 131 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.